Case | Age (years), gender | Underly diseases | ARDS severity | Ventilation settings | Guidance | Freezing time | Sample number and size | Complication | Finial pathology | Management changes | Outcome |
---|---|---|---|---|---|---|---|---|---|---|---|
1 | 39/F | MS | Severe | PCV (PC 14 cmH2O, FiO2 90%, PEEP 11 cmH2O) and ECMO (4500 rpm, blood flow 6.3 L/min, gas flow 4 L/min, FiO2 100%) | RP-EBUS | 2.4 mm/4 s | 2/20, 30 mm2 | Severe bleeding | Fibrotic phase of DAD with underly infection | changes in antibiotic drugs and steroid discontinuation | Died |
2 | 68/M | NS | Severe | PCV (PC 16 cmH2O, FiO2 40%, PEEP 6 cmH2O) and ECMO (3120 rpm, blood flow 3.86 L/min, gas flow 3.5 L/min, FiO2 100%) | RP-EBUS | 2.4 mm/4 s | 3/12, 20, 35 mm2 | Mild bleeding | Proliferative phase of DAD with CMV inclusion | initiation of high-dose steroid and antivirus treatment | Rehab |
3 | 62/F | IGT | Severe | PCV (PC 24 cmH2O, FiO2 70%, PEEP 10 cmH2O) | RP-EBUS | 2.4 mm/4 s | 4/9, 12, 16, 25 mm2 | Mild bleeding | Foreign body granulomas | initiation of high-dose steroid and a determination of the aspiration etiology | Rehab |
4 | 65/F | CA | Severe | PCV (PC 20 cmH2O, FiO2 100%, PEEP 8 cmH2O) | RP-EBUS | 2.4 mm/4 s | 4/9, 12, 16, 25 mm2 | Severe bleeding | Fibrotic NSIP | steroid discontinuation and transitioned to palliative measures | Died |
5 | 31/M |  | moderate | HFNC (FiO2 40%, gas flow rate 60 L/min) | RP-EBUS and CBCT | 2.4 mm/4 s | 4/9, 15, 24, 42 mm2 | Mild bleeding | COP | initiation of high-dose steroid | Rehab |